FOLH1 and prostate carcinoma: In recent years, PSMA-PET/CT with [18F]PSMA-1007, besides [68Ga]Ga-PSMA-11, revolutionized PET imaging and imaging-guided therapy of prostate cancer patients with biochemical recurrence [1,2,3,4,5,6].